Koshkin Sergey, Danilova Anna, Raskin Grigory, Petrov Nikolai, Bajenova Olga, O'Brien Stephen J, Tomilin Alexey, Tolkunova Elena
Institute of Cytology, Russian Academy of Sciences, Tikhoretsky ave. 4, St. Petersburg, Russia, 194064.
N.N. Petrov Oncology Research Institute, St. Petersburg, 197758, Russia.
Tumour Biol. 2016 Sep;37(9):12833-12842. doi: 10.1007/s13277-016-5214-8. Epub 2016 Jul 23.
The principal cause of death in cancer involves tumor progression and metastasis. Since only a small proportion of the primary tumor cells, cancer stem cells (CSCs), which are the most aggressive, have the capacity to metastasize and display properties of stem cells, it is imperative to characterize the gene expression of diagnostic markers and to evaluate the drug sensitivity in the CSCs themselves. Here, we have examined the key genes that are involved in the progression of colorectal cancer and are expressed in cancer stem cells. Primary cultures of colorectal cancer cells from a patient's tumors were studied using the flow cytometry and cytological methods. We have evaluated the clinical and stem cell marker expression in these cells, their resistance to 5-fluorouracil and irinotecan, and the ability of cells to form tumors in mice. The data shows the role of stem cell marker Oct4 in the resistance of primary colorectal cancer tumor cells to 5-fluorouracil.
癌症的主要死因涉及肿瘤进展和转移。由于原发性肿瘤细胞中只有一小部分,即最具侵袭性的癌症干细胞(CSCs),具有转移能力并表现出干细胞特性,因此表征诊断标志物的基因表达并评估癌症干细胞自身的药物敏感性至关重要。在此,我们研究了参与结直肠癌进展并在癌症干细胞中表达的关键基因。使用流式细胞术和细胞学方法对来自患者肿瘤的结直肠癌细胞进行原代培养。我们评估了这些细胞中的临床和干细胞标志物表达、它们对5-氟尿嘧啶和伊立替康的耐药性以及细胞在小鼠体内形成肿瘤的能力。数据显示干细胞标志物Oct4在原发性结直肠癌肿瘤细胞对5-氟尿嘧啶的耐药性中所起的作用。